Institutional investors purchased a net $3.7 million shares of ALEC during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 73.42% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.5 Million shares of Alector Inc
MORGAN STANLEY & CO. LLC Bought 1.2 Million shares of Alector Inc
T. ROWE PRICE ASSOCIATES, INC. (... Bought 475.0 Thousand shares of Alector Inc